Quanterix (QTRX) Capital Expenditures Growth (1y) (2018 - 2026)
Quanterix (QTRX) Capital Expenditures Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 15.89% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -11.95% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -47.73% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 106.98% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Quanterix | 184.16 Mn | 84.89 Mn | 15.57 Mn | -93.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -93.07% |
| Dec 31, 2025 | -124.94% |
| Sep 30, 2025 | -36.36% |
| Jun 30, 2025 | -58.74% |
| Mar 31, 2025 | 465.77% |
| Dec 31, 2024 | 253.00% |
| Sep 30, 2024 | -440.00% |
| Jun 30, 2024 | 106.02% |
| Mar 31, 2024 | 572.73% |
| Dec 31, 2023 | -117.74% |
| Sep 30, 2023 | -102.44% |
| Jun 30, 2023 | 91,500.00% |
| Mar 31, 2023 | 3,400.00% |
| Dec 31, 2022 | 159,600.00% |
| Sep 30, 2022 | 236.60% |
| Jun 30, 2022 | -100.01% |
| Mar 31, 2022 | -101.27% |
| Dec 31, 2021 | -100.08% |
| Sep 30, 2021 | -3,280.65% |
| Jun 30, 2021 | 10,935.82% |